PD 123319 ditrifluoroacetate

1 1

Selleck Chemicals

E7998

€0,00 EUR
€0,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

PD 123319 ditrifluoroacetate is an antagonist linked to GPCR Signaling and related pathway-oriented research. It is especially relevant in cardiovascular models, where defined compound exposure can be linked to receptor-driven second-messenger signaling and desensitization dynamics.

The pathway annotation connects PD 123319 ditrifluoroacetate to GPCR Signaling, supporting experiments that monitor receptor-driven second-messenger signaling and desensitization dynamics across biochemical, cellular, or phenotypic assay formats. This context is compatible with ligand-response, cAMP, calcium-flux, and receptor-pharmacology assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In cardiovascular models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Pathway perturbation studies connected to GPCR Signaling
  • Receptor-blockade and ligand-competition studies
  • Phenotypic profiling in cardiovascular models
  • Combination studies with orthogonal perturbagens

Overall, PD 123319 ditrifluoroacetate is well suited to pathway-oriented studies that need a defined compound input for GPCR Signaling readouts in cardiovascular models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Pathways:
GPCR Signaling
Research Area:
Cardiovascular
CAS No.:
136676-91-0
Molecular Weight:
736.66
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.